SHENZHEN, China I 14, 2025 I Kexing Biopharm Co., Ltd. (Stock Code: 688136.SH) recently announced that the Investigational New Drug Application (IND) ...

For decades, lab-made antibodies have been used to support patients fighting specific diseases. These treatments have become ...

Stock analysts at Leerink Partnrs lowered their FY2025 earnings estimates for MoonLake Immunotherapeutics in a report issued on Wednesday, February 5th. Leerink Partnrs analyst T. Smith now ...

The Sudan virus, a close relative of Ebola, has a fatality rate of 50% but remains poorly understood in terms of how it ...

MoonLake Immunotherapeutics, a rising star in the biotech world, has emerged as a growing player in Cambridge’s biotech ...

Detailed price information for GT Biopharma Inc (GTBP-Q) from The Globe and Mail including charting and trades.

SHENZHEN, China, Jan. 24, 2025 /PRNewswire/ -- From January 13 to 16, Dr. Huiming Li, Deputy General Manager of Kexing Biopharm New Drug Research Center, attended the 17th Biotech Showcase ...

Get Instant Summarized Text (Gist) A new PET imaging probe has been developed to detect inflammation with high sensitivity and selectivity by targeting CD45, a marker on immune cells. It provides ...

This useful manuscript provides a newly curated database (termed AACDB) of antibody-antigens structural information, alongside annotations that are either taken and from the PDB, or added de-novo.

In the system designed by Arimura et al., the SpyTag peptide is bound to a nanobody that specifically binds to a tag in the complex of interest. This allowed the chromatosome complex within frog egg ...

"Obesity is gradually eroding human health," and the global prevalence of obesity (BMI > 30) is predicted to reach 25 % by 2035, affecting nearly 1.9 billion people. The demand for medications to ...